These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 33444606

  • 21. A novel hamster nonalcoholic steatohepatitis model induced by a high-fat and high-cholesterol diet.
    Miyaoka Y, Jin D, Tashiro K, Masubuchi S, Ozeki M, Hirokawa F, Hayashi M, Takai S, Uchiyama K.
    Exp Anim; 2018 May 10; 67(2):239-247. PubMed ID: 29311502
    [Abstract] [Full Text] [Related]

  • 22. Hepatic Transcriptome Profiles of Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E.
    Kobori M, Takahashi Y, Sakurai M, Ni Y, Chen G, Nagashimada M, Kaneko S, Ota T.
    Int J Mol Sci; 2017 Mar 08; 18(3):. PubMed ID: 28282876
    [Abstract] [Full Text] [Related]

  • 23. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ, Leeming DJ, Detlefsen S, Bruun MF, Hjuler ST, Henriksen K, Hein P, Karsdal MA, Brockbank S, Cruwys S.
    Biomed Pharmacother; 2019 Mar 08; 111():926-933. PubMed ID: 30841472
    [Abstract] [Full Text] [Related]

  • 24. Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis.
    Nestor JJ, Parkes D, Feigh M, Suschak JJ, Harris MS.
    Sci Rep; 2022 Apr 23; 12(1):6666. PubMed ID: 35461369
    [Abstract] [Full Text] [Related]

  • 25. Hepatoprotective effects of ZLY16, a dual peroxisome proliferator-activated receptor α/δ agonist, in rodent model of nonalcoholic steatohepatitis.
    Zhou Z, Deng L, Hu L, Ren Q, Cai Z, Wang B, Li Z, Zhang L.
    Eur J Pharmacol; 2020 Sep 05; 882():173300. PubMed ID: 32592770
    [Abstract] [Full Text] [Related]

  • 26. Elafibranor interrupts adipose dysfunction-mediated gut and liver injury in mice with alcoholic steatohepatitis.
    Li TH, Yang YY, Huang CC, Liu CW, Tsai HC, Lin MW, Tsai CY, Huang SF, Wang YW, Lee TY, Huang YH, Hou MC, Lin HC.
    Clin Sci (Lond); 2019 Feb 14; 133(3):531-544. PubMed ID: 30602573
    [Abstract] [Full Text] [Related]

  • 27. Electronegative LDL is linked to high-fat, high-cholesterol diet-induced nonalcoholic steatohepatitis in hamsters.
    Lai YS, Yang TC, Chang PY, Chang SF, Ho SL, Chen HL, Lu SC.
    J Nutr Biochem; 2016 Apr 14; 30():44-52. PubMed ID: 27012620
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis.
    Roth JD, Feigh M, Veidal SS, Fensholdt LK, Rigbolt KT, Hansen HH, Chen LC, Petitjean M, Friley W, Vrang N, Jelsing J, Young M.
    World J Gastroenterol; 2018 Jan 14; 24(2):195-210. PubMed ID: 29375205
    [Abstract] [Full Text] [Related]

  • 31. Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.
    Duparc T, Briand F, Trenteseaux C, Merian J, Combes G, Najib S, Sulpice T, Martinez LO.
    Am J Physiol Gastrointest Liver Physiol; 2019 Oct 01; 317(4):G508-G517. PubMed ID: 31460789
    [Abstract] [Full Text] [Related]

  • 32. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N, Zou A, Ghosh P, Ahamed F, Delker D, Zhang Y.
    J Biol Chem; 2020 Jan 24; 295(4):994-1008. PubMed ID: 31831621
    [Abstract] [Full Text] [Related]

  • 33. RLA8-A New and Highly Effective Quadruple PPAR-α/γ/δ and GPR40 Agonist to Reverse Nonalcoholic Steatohepatitis and Fibrosis.
    Li MH, Chen W, Wang LL, Sun JL, Zhou L, Shi YC, Wang CH, Zhong BH, Shi WG, Guo ZW.
    J Pharmacol Exp Ther; 2019 Apr 24; 369(1):67-77. PubMed ID: 30745416
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis.
    Tølbøl KS, Stierstorfer B, Rippmann JF, Veidal SS, Rigbolt KTG, Schönberger T, Gillum MP, Hansen HH, Vrang N, Jelsing J, Feigh M, Broermann A.
    Dig Dis Sci; 2019 May 24; 64(5):1238-1256. PubMed ID: 30511198
    [Abstract] [Full Text] [Related]

  • 36. Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.
    Charlton M, Krishnan A, Viker K, Sanderson S, Cazanave S, McConico A, Masuoko H, Gores G.
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov 24; 301(5):G825-34. PubMed ID: 21836057
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G, Jackson CV, Zimmerman K, Zhang LK, Finnearty CM, Sandusky GE, Zhang G, Peterson RG, Wang YJ.
    BMC Gastroenterol; 2019 Mar 18; 19(1):41. PubMed ID: 30885145
    [Abstract] [Full Text] [Related]

  • 39. Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice.
    Lee SM, Muratalla J, Karimi S, Diaz-Ruiz A, Frutos MD, Guzman G, Ramos-Molina B, Cordoba-Chacon J.
    Cell Mol Life Sci; 2023 Jan 11; 80(2):39. PubMed ID: 36629912
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.